Hyloris Pharmaceuticals SA

ENXTBR:HYL Stock Report

Market Cap: €166.9m

Hyloris Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of HYL?
Owner TypeNumber of SharesOwnership Percentage
Institutions76,1740.272%
General Public12,011,09542.9%
Individual Insiders15,913,10556.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 10 shareholders own 57.1% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
36.7%
Stijn Van Rompay
10,268,701€61.2m0%no data
13.8%
Thomas Jacobsen
3,857,838€23.0m0%no data
6.17%
Bart Versluys
1,727,623€10.3m0%no data
0.15%
Mandarine Gestion
42,500€253.3k0%0.01%
0.12%
Dietmar Aichhorn
32,500€193.7k0%no data
0.087%
Degroof Petercam Asset Management
24,370€145.2k0%no data
0.062%
Koenraad Van Der Elst
17,443€104.0k0%no data
0.032%
Jean-Luc Vandebroek
9,000€53.6k0%no data
0.021%
Dimensional Fund Advisors LP
5,804€34.6k0%no data
0.013%
Claresco Finance
3,500€20.9k0%0.01%